Abiomed (ABMD) Tops Q1 EPS by 6c

July 28, 2016 7:24 AM EDT

Abiomed (NASDAQ: ABMD) reported Q1 EPS of $0.29, $0.06 better than the analyst estimate of $0.23. Revenue for the quarter came in at $103 million versus the consensus estimate of $97.23 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings